Our Press Releases | Association for Accessible Medicines

New Blog - Jonathan Kimball gives more detail re: AAM's blueprint & proposed policy framework

Jan 23, 2020 | Rachel Schwartz

AAM Statement on Avalere Analysis of Generic Substitution

Jan 16, 2020 | Rachel Schwartz

AAM Statement on Senate Passage of USMCA Agreement

Jan 8, 2020 | Rachel Schwartz

AAM Statement on "The Unintended Economics of the BLOCKING Act" Report

Jan 7, 2020 | Rachel Schwartz

Katherine Michelle Raab Joins AAM as Vice President, Federal Government Affairs

Dec 19, 2019 | Rachel Schwartz

USMCA Sets a New Standard for Lowering Drug Prices and Expanding Access to Medicines

Dec 17, 2019 | Rachel Schwartz

AAM Applauds House Passage of the CREATES Act

AAM Statement on H3

Dec 13, 2019 | Rachel Schwartz

AAM Statement on HR 3

Dec 10, 2019 | Rachel Schwartz

USMCA Trade Agreement: A Victory for America’s Patients

Dec 9, 2019 | Rachel Schwartz

AAM Opposes the Lower Health Care Costs Act

FDA - Nomination of Dr. Stephen Hahn to FDA

Nov 1, 2019 | Rachel Schwartz

AAM Statement on Nomination of Dr. Stephen Hahn to FDA

AAM Statement on 2019 FDA Drug Shortages

Oct 29, 2019 | Rachel Schwartz

AAM Statement on 2019 FDA Drug Shortages Task Force Report

Oct 23, 2019 | Rachel Schwartz

AAM Launches #DoesntAddUp Ad Campaign to Bring Down Prescription Drug Costs for Patients in the U.S.